Q1 2021 Oncolytics Biotech Inc Earnings Call and Annual Corporate Update Transcript
Good afternoon, and welcome to the Annual Meeting of Shareholders of Oncolytics Biotech Inc. My name is Kirk Look, and I'm the Chief Financial Officer of Oncolytics, and I will be serving as Chair of this meeting. Joining me today is Matt Coffey, President and CEO; as well, we have Wayne Pisano, Deborah Brown, Angela Holtham, Leon Kruimer, Bernd Seizinger and Bill Rice, who, I believe, have joined us online. Other members of management also joining us online are Allison Hagerman, Andrew de Guttadauro and Tom Heineman.
Now for convenience, we have divided today's meeting into 2 parts. (technical difficulty) After we conclude the formal part of the meeting, we will provide a brief corporate update with a general Q&A at the end.
Before we begin with the formal business portion of the meeting, I will provide some comments on voting and questions at today's meeting. Now as with any technology, unexpected glitches may occur and we appreciate your patience. Our service providers for this platform at Lumi and AST are very experienced at running
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |